OCGN
Ocugen, Inc.
$1.51
+4.86%
2026-05-08
About Ocugen, Inc.
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel recombinant fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
Key Fundamentals
Forward P/E
13.16
EPS (TTM)
$-0.24
ROE
-776.9%
Revenue Growth (YoY)
54.2%
Profit Margin
0.0%
Debt/Equity
933.03
Price/Book
170.00
Beta
2.31
Market Cap
$501.0M
Avg Volume (10D)
9.4M
Recent Breakout Signals
No recent breakout signals detected for OCGN.
Recent Price Range (60 Days)
60D High
$2.72
60D Low
$1.38
Avg Volume
8.7M
Latest Close
$1.51
Get breakout alerts for OCGN
Sign up for Breakout Scanner to receive daily notifications when OCGN triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Ocugen, Inc. (OCGN) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors OCGN daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. OCGN operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.